Biomedical Materials Drug Delivery, Implants, and Tissue Engineering: Volume 550. MRS Proceedings – Biomaterials, Biotechnology, Healthcare Industries

The Biomedical Materials Drug Delivery, Implants, and Tissue Engineering: Volume 550. MRS Proceedings Report has been published. It provides updated in 2018 year analysis of industries from Biomaterials, Biotechnology, Healthcare Markets.

The continual growth and increasing sophistication of biomaterials industries has been driven in large part by advances in the basic sciences of the materials involved. Indeed, advances in understanding biological systems at the molecular level have quickly been exploited by materials scientists to develop more sophisticated approaches to therapeutics and diagnostics. The interdisciplinarity and breadth of the biomaterials field necessitates the close co-operation of scientists in many different fields, including materials science, chemistry, biology, engineering and medicine. This book, first published in 1999, brings together researchers in many of these converging fields to report on advances and to stimulate further discussion and research in these vital areas of discovery and development. Topics include: polymeric drugs and delivery; musculoskeletal tissue engineering; scaffolds and cell seeding – fabrication and characterization techniques; biological cues and organic/inorganic hybrids; novel materials, porous structure and tissue engineering; and orthopaedic bearing surfaces and novel coatings.

Read more and order at Biomedical Materials Drug Delivery, Implants, and Tissue Engineering: Volume 550. MRS Proceedings

Biomedical Foams for Tissue Engineering Applications – Biomaterials, Biotechnology, Healthcare Industries

The Biomedical Foams for Tissue Engineering Applications Report has been published. It provides updated in 2018 year analysis of industries from Biomaterials, Biotechnology, Healthcare Markets.

Biomedical foams are a new class of materials, which are increasingly being used for tissue engineering applications. Biomedical Foams for Tissue Engineering Applications provides a comprehensive review of this new class of materials, whose structure can be engineered to meet the requirements of nutrient trafficking and cell and tissue invasion, and to tune the degradation rate and mechanical stability on the specific tissue to be repaired.

Part one explores the fundamentals, properties, and modification of biomedical foams, including the optimal design and manufacture of biomedical foam pore structure for tissue engineering applications, biodegradable biomedical foam scaffolds, tailoring the pore structure of foam scaffolds for nerve regeneration, and tailoring properties of polymeric biomedical foams. Chapters in part two focus on tissue engineering applications of biomedical foams, including the use of bioactive glass foams for tissue engineering applications, bioactive glass and glass-ceramic foam scaffolds for bone tissue restoration, composite biomedical foams for engineering bone tissue, injectable biomedical foams for bone regeneration, polylactic acid (PLA) biomedical foams for tissue engineering, porous hydrogel biomedical foam scaffolds for tissue repair, and titanium biomedical foams for osseointegration.

Biomedical Foams for Tissue Engineering Applications is a technical resource for researchers and developers in the field of biomaterials, and academics and students of biomedical engineering and regenerative medicine.

– Explores the fundamentals, properties, and modification of biomedical foams
– Includes intense focus on tissue engineering applications of biomedical foams
– A technical resource for researchers and developers in the field of biomaterials, and academics and students of biomedical engineering and regenerative medicine

Read more and order at Biomedical Foams for Tissue Engineering Applications

The World Market for Prepared Culture Media for the Development of Micro-organisms: A 2018 Global Trade Perspective – Biomaterials, Biotechnology, Healthcare Industries

The The World Market for Prepared Culture Media for the Development of Micro-organisms: A 2018 Global Trade Perspective Report has been published. It provides updated in 2018 year analysis of industries from Biomaterials, Biotechnology, Healthcare Markets.

This series was created for international firms who rely on foreign markets for a substantial portion of their business or who might be threatened by international competition. The estimates given in this report were created using a methodology developed by and implemented under the direct supervision of Professor Philip M. Parker, the INSEAD Chair Professor of Management Science. The methodology relies on historical figures across countries. The figures should be seen as market estimates, as opposed to historical records, as these are projected for a specific year of trade.

1 METHODOLOGY

1.1 OUR APPROACH

This report was created for strategic planners, international executives and import/export managers who are concerned with the market for prepared culture media for the development of micro-organisms. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for prepared culture media for the development of micro-organisms for those countries serving the world market via exports or supplying from various countries via imports. I do so for a specific year based on a variety of key historical indicators and econometric models.

On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying prepared culture media for the development of micro-organisms? What is the dollar value of these imports? How much do the imports of prepared culture media for the development of micro-organisms vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of prepared culture media for the development of micro-organisms? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?

In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported prepared culture media for the development of micro-organisms. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to a specific year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive in a specific year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.

After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of prepared culture media for the development of micro-organisms, for each individual country. Chapter 4 does the same, but for imports of prepared culture media for the development of micro-organisms for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of prepared culture media for the development of micro-organisms to and from all major countries in the world. Of the countries considered, if a country is not reported here it is therefore estimated to have only a negligible level of trade in prepared culture media for the development of micro-organisms (i.e. their market shares are close or equal to zero percent). "Prepared Culture Media for the Development of Micro-organisms" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "prepared culture media for the development of micro-organisms" is 59867.

For more information on this definition, please refer to the following web site:

Important Caveat. The figures should be seen as market estimates, as opposed to historical records, as these are forecasted for a specific year of trade. More importantly, in light of the fact that unforeseeable factors might interrupt markets in achieving their reported levels, the figures should be seen as estimates of potential. For example, "mad cow" disease, foot-and-mouth disease, trade embargoes, labor disputes, military conflicts, acts of terrorism and other events will certainly affect the actual trade flows recorded for a variety of industry or product categories. In such cases, the difference between the numbers given in this report and the numbers actually observed might be interpreted as the "net loss" or "net gain" due to these exogenous events affecting regular trade flows that would have occurred had these events not have taken place.

Read more and order at The World Market for Prepared Culture Media for the Development of Micro-organisms: A 2018 Global Trade Perspective

CAS 148411-57-8 Chitosan lactate (ester) Chemical World Report – Biomaterials, Biotechnology, Healthcare Industries

The CAS 148411-57-8 Chitosan lactate (ester) Chemical World Report Report has been published. It provides updated in 2018 year analysis of industries from Biomaterials, Biotechnology, Healthcare Markets.

CAS 148411-57-8 Chitosan lactate (ester) Chemical World Report

This CAS 148411-57-8 – Chitosan lactate (ester) Chemical World Consumption Report provides data on the net consumption of Chitosan lactate (ester) in each of the countries listed. The substance covered (Chitosan lactate (ester)) are classified by the Chemical Registry, EC, EU, CAS, or other coding system. In addition, where available this consumption is further analysed by Application or End User sector.

The Chitosan lactate (ester) World Consumption Report definitions:

Name: Chitosan lactate (ester)
: Chitosan-lactate-ester; Chitosan 2-hydroxypropanoate (ester)
Synonyms: Chitosan 2-hydroxypropanoate (ester)

Chemical Registry number: 769198053064
CAS Number 148411-57-8

The Chitosan lactate (ester) Report gives Market Consumption / Products / for over 200 countries by 3 Time series: From 1997- 2016 and Forecasts 2017- 2024 & 2024-2028.

59 Market Research Chapters.

Spreadsheet Chapters:
– Market Consumption – in US$ by Country by Product by Year.
– Market
– Financial
– Competitive
– Market Segmentation
– Industry
– Critical Parameters
– Marketing Costs Markets
– Decision Makers
– Performance
– Product Launch

World & National Report Market Database & Spreadsheets. Financial Spreadsheets & Databases. Industry Spreadsheets & Databases.

Data includes Market Consumption by individual Product / Service, Per-Capita Consumption, Marketing Costs & Margins, Product Launch Data, Buyers, End Users & Customer Profile, Consumer Demographics. Historic Balance Sheets, Forecast Financial Data, Industry Profile, National Data.

This report consists of a download Zipped file (300-1200MB), plus a DVD, containing the entire report web and databases. The tables & databases are in A World & National Report Market Database & Spreadsheets. Financial Spreadsheets & Databases. Industry Spreadsheets & Databases.
The tables & databases are in Access & Excel formats which enable readers to produce their own spreadsheet calculations and modelling. There are five additional DVDs available which provide Ancillary Data, Tools, and Utilities for the analysis and handling of the databases. This database is updated monthly. After-Sales and update services available from The Data Institute.

Chitosan lactate (ester) Products/ Markets covered, 2025 pages, 9857 spreadsheets, 9727 database tables, 586 illustrations. Updated monthly. 12 month After-Sales Service.

Read more and order at CAS 148411-57-8 Chitosan lactate (ester) Chemical World Report

Biomimetic Principles and Design of Advanced Engineering Materials – Biomaterials, Biotechnology, Healthcare Industries

The Biomimetic Principles and Design of Advanced Engineering Materials Report has been published. It provides updated in 2018 year analysis of industries from Biomaterials, Biotechnology, Healthcare Markets.

This book explores the structure–property–process relationship of biomaterials from engineering and biomedical perspectives, and the potential of bio–inspired materials and their applications. A large variety of natural materials with outstanding physical and mechanical properties have appeared in the course of evolution. From a bio–inspired viewpoint, materials design requires a novel and highly cross disciplinary approach. Considerable benefits can be gained by providing an integrated approach using bio–inspiration with materials science and engineering.

The book is divided into three parts; Part One focuses on mechanical aspects, dealing with conventional material properties: strength, toughness, hardness, wear resistance, impact resistance, self–healing, adhesion, and adaptation and morphing. Part Two focuses on functional materials with unique capabilities, such as self–cleaning, stimuli–response, structural color, anti–reflective materials, catalytic materials for clean energy conversion and storage, and other related topics. Part Three describes how to mimic natural materials processes to synthesize materials with low cost, efficient and environmentally friendly approaches. For each chapter, the approach is to describe situations in nature first and then biomimetic materials, fulfilling the need for an interdisciplinary approach which overlaps both engineering and materials science.

Read more and order at Biomimetic Principles and Design of Advanced Engineering Materials

Global Collagen Biomaterial Market: Analysis By Source, By Application, By Region, By Country: Opportunities and Forecast (2017-2022) – Biomaterials, Biotechnology, Healthcare Industries

The Global Collagen Biomaterial Market: Analysis By Source, By Application, By Region, By Country: Opportunities and Forecast (2017-2022) Report has been published. It provides updated in 2018 year analysis of industries from Biomaterials, Biotechnology, Healthcare Markets.

"Global Collagen Biomaterial Market: Analysis By Source, By Application, By Region, By Country: Opportunities and Forecast (2017-2022) – By Source (Bovine, Porcine, Marine, Others), By Application (Tissue Engineering, Drug Delivery System, Others), By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Mexico, Germany, U.K., China, India, Brazil, Saudi Arabia)"

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Collagen Biomaterial Market on the basis of Source (Bovine, Porcine, Marine & Others), By Application (Tissue Engineering, Drug Delivery System and Others), Regulations: Opportunities and Forecasts (2017-2022), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, Mexico, U.K., Germany, China, India, Brazil and Saudi Arabia).

Over the recent years, the global Collagen Biomaterial industry has been growing rapidly owing to aging population, rising number of people with orthopedic disorders and high demand in bone graft substitute and wound healing market. Globally, the growth in Collagen Biomaterial market is driven by increased investment in research & development.

According to the report, “Global Collagen Biomaterial Market: Analysis By Source, By Application, By Region, By Country: Opportunities and Forecast (2017-2022) – By Source (Bovine, Porcine, Marine, Others), By Application (Tissue Engineering, Drug Delivery System, Others), By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Mexico, Germany, U.K., China, India, Brazil, Saudi Arabia)”, global market is projected to display a robust growth represented by a CAGR of 9.15% during 2017-2022, chiefly driven by aging population and rising incidences of orthopaedic disorders.

Among the source, bovine collagen currently dominates the collagen biomaterial market. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by rising awareness about regenerative medicine, large population, rapid economic development and improvement in healthcare infrastructure.

The report titled “Global Collagen Biomaterial Market: Analysis By Source, By Application, By Region, By Country: Opportunities and Forecast (2017-2022) – By Source (Bovine, Porcine, Marine, Others), By Application (Tissue Engineering, Drug Delivery System, Others), By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Mexico, Germany, U.K., China, India, Brazil, Saudi Arabia)” has covered and analysed the potential of Global Neurology Market and provides statistics and information on market size, shares and growth factors.

The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)

  • Global Collagen Biomaterial Market
  • By Source (Bovine, Porcine, Marine & Others)
  • By Application (Tissue Engineering, Drug Delivery System, Others)

Regional Markets – N. America, Europe, APAC, and ROW (Actual Period: 2012-2016, Forecast Period: 2017-2022)

  • Collagen Biomaterial Market
  • Collagen Biomaterial Market, By Source
  • Collagen Biomaterial Market, By Application

Country Analysis – US, Canada, Mexico, UK, Germany, China, India, Brazil, Saudi Arabia (Actual Period: 2012-2016, Forecast Period: 2017-2022)

  • Collagen Biomaterial Market
  • Collagen Biomaterial Market, By Type
  • Collagen Biomaterial Market, By Source

Other Report Highlights

  • Market Dynamics – Trends, Drivers, Challenges
  • Policy and Regulation
  • Company Analysis – Collagen Solutions, Advanced BioMatrix, Collagen Matrix, Medtronic Plc, Nippi Inc, KYERON BV, EternoGen, CollPlant, Botiss Biomaterial, Cologenesis

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Read more and order at Global Collagen Biomaterial Market: Analysis By Source, By Application, By Region, By Country: Opportunities and Forecast (2017-2022)

Europe Bioadhesive Market – Forecasts from 2017 to 2022 – Biomaterials, Biotechnology, Healthcare Industries

The Europe Bioadhesive Market – Forecasts from 2017 to 2022 Report has been published. It provides updated in 2018 year analysis of industries from Biomaterials, Biotechnology, Healthcare Markets.

Europe Bioadhesive Market is projected to grow at a CAGR of 12.43%, reaching a market size of US$1,308 million in 2022, increasing from US$648 million in 2017. The tightening environmental regulations towards VOC emissions, coupled with the shift from synthetic adhesives to bioadhesives by the manufacturers is driving the market growth.

Research Methodology

The first section of the report deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.

Market Dynamics

Next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry and regional regulations which are determining the product specifications and a brief technological aspect of Bioadhesive. Complete industry analysis has also been covered by Porter’s five forces model as a part of this report section.

Segmentation

Europe Bioadhesive Market has been segmented by source, industry vertical, and country.

By Source:
Plant Based
Animal Based

By Industry Vertical:
Packaging
Construction
Healthcare
Consumer Goods
Others

By Country:
United Kingdom
Germany
France
Spain
Others

Market Players

Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Henkel, 3M, Danimer Scientific LLC, and Dow among others.

Read more and order at Europe Bioadhesive Market – Forecasts from 2017 to 2022

Japanese Orthopedic Biomaterials Markets 2013 – MedSuite – Biomaterials, Biotechnology, Healthcare Industries

The Japanese Orthopedic Biomaterials Markets 2013 – MedSuite Report has been published. It provides updated in 2018 year analysis of industries from Biomaterials, Biotechnology, Healthcare Markets.

The Japanese orthopedic biomaterials market is expected to approach $1.5 billion by 2019. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Japanese orthopedic biomaterials market.
The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented only into synthetics) and hyaluronic acid (HA) viscosupplementation. Although the market has reached maturity in Japan, it is expected to continue to grow as a result of the large aging population. Further growth in the overall market will be fuelled by the increased value of the HA viscosupplementation segment. This is due to the continued use of premium priced three-injection cycle products in Japan that were introduced in December 2010.
Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for Japan.
Report Contents:
Competitor Analysis
Identified Strategic Opportunities
Market Overview by Segment & Country
Trend Analysis by Segment & Country
Market Drivers & Limiters
Mergers & Acquisitions
Customer Feedback and Market Monitoring
Main Markets Included:
Bone Graft Substitute
Hyaluronic Acid Viscosupplementation
Sub-Segments Included:
Autograft
Non-Proprietary Allograft
Synthetic Allograft
Demineralized Bone Matrix
Cervical Spine
Thoracolumbar Spine
Trauma & Reconstruction
Craniomaxillofacial
Single-injection products
Three-injection cycle products
Five-injection cycle products
Companies Included:
Seikagaku (Kaken)
Chugai Genzyme (Teijin)
Maruho
Meiji Seika Kaisha
Taisho
Olympus Terumo
Hoya/Pentax
Japan Medicalnext
Kyocera Medical
Others include: Biomet, JMDM, Mizuho, NGKNTK, Stryker, Zimmer and local Japanese pharmaceutical
companies.
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Read more and order at Japanese Orthopedic Biomaterials Markets 2013 – MedSuite

Global Bioactive Material Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023 – Biomaterials, Biotechnology, Healthcare Industries

The Global Bioactive Material Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023 Report has been published. It provides updated in 2018 year analysis of industries from Biomaterials, Biotechnology, Healthcare Markets.

The global bioactive material market is estimated to reach $2.85 billion by 2022 and is expected to grow at CAGR of 13.8% during 2016-2022.

The bioactive material market is majorly driven by the rising demand of bioactive material in various regions. The key drivers of this market are growing cases of organs failure, increasing use of spinal and orthopedic procedures, rising use of synthetic materials in grafting process and rising ageing population. However, the Metaphyseal defect also known as autoimmune defect is the major factor which is hindering the growth of the global bioactive material market. In addition, high costs of new technologies is also hampering the growth of the global bioactive material. The global bioactive material market has large number of opportunities such as increasing cases of disease and need for advanced treatment procedures in emerging countries.

The bioactive material market is segmented on the basis of material, type, production method, application and geography. On the basis of material, the market is segmented into ceramics, glass, glass-ceramics, composites and others. Based on the type, the market is segmented into powders and nano powders, granules, monoliths, moldable and injectable products and coatings. Based on the production method, the market is segmented into seven categories such as melting, sol-gel, specialty processes for glass and glass-ceramics, milling and sintering, spray-drying, plastic processing and impregnation. Based on the application, the market is segmented into dentistry, medicine, pharmaceuticals, surgery, bioengineering and others. Bioactive materials are widely used in almost every sectors of medicine, pharmaceuticals and dentistry.

The bioactive material market is in different stages of growth in different countries. North America dominates the bioactive material market with the largest share because of large investments in healthcare sector and increasing number of minimally invasive surgeries. After North America , the demand for bioactive materials is also increasing in Asia Pacific, mainly in India, China and Japan due to increasing healthcare expenditure and disposal incomes, and increasing ageing population. As increasing ageing population results in growth of trauma and orthobiologic surgeries, it will in turn drive the global bioactive material market.

The bioactive material market is dominated by some of the major key players such as 3Di, Aap Implantate, Arthrex, Baxter, Berkeley advanced, Biomatlante, Biomet, Curasan, Integra Life Science, Dentsply, Heraeus Kulzer, Kyocera, Novabone, and many more. Innovation, agreements, collaboration, partnerships and expansion is regarded as the key strategies to have a strong hold in the market and maintain a global presence. On 20 April, 2015, Aap Implantate, a manufacturer, distributer, and developer of biomaterials and enhanced trauma products, declared that the European Patent Office newly granted it an essential patent for silver coating technology for health implants. The European patent looks after the multifunctional antibacterial silver coating manufactured by the company for implants and relevant medical tools for the invention of coating.


Note:
Please allow up to 72 hours for delivery.

Read more and order at Global Bioactive Material Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

Germany Tissue Engineered – Skin Substitutes Market Outlook to 2024 – Biomaterials, Biotechnology, Healthcare Industries

The Germany Tissue Engineered – Skin Substitutes Market Outlook to 2024 Report has been published. It provides updated in 2018 year analysis of industries from Biomaterials, Biotechnology, Healthcare Markets.

Germany Tissue Engineered – Skin Substitutes Market Outlook to 2024

Summary

The new report, "Germany Tissue Engineered – Skin Substitutes Market Outlook to 2024", provides key market data on the Germany Tissue Engineered – Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments – Biologic Skin Substitutes, Biosynthetic Skin Substitutes and Synthetic Skin Substitutes.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Tissue Engineered – Skin Substitutes market segments – Biologic Skin Substitutes, Biosynthetic Skin Substitutes and Synthetic Skin Substitutes.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the Germany Tissue Engineered – Skin Substitutes market.
  • Key players covered include Ethicon US LLC, Baxter International Inc, Integra LifeSciences Corp and C. R. Bard Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Read more and order at Germany Tissue Engineered – Skin Substitutes Market Outlook to 2024